Artificial intelligence | Pharmaceuticals | Regulatory Rapporteur

Skip to main content
Skip to navigation

Artificial intelligence articles

TOPRA Annual Lecture 2026: The Global Imperative for Responsible AI in Healthcare

2026-03-05T17:11:00+00:00By Victoria Goff

This article summarises the discussions at TOPRA’s Annual Lecture 2026, which focused on the responsible global govenance of AI in healthcare

DIN SPEC 91509: A milestone for structured, digital medical device documentation
2026-01-30T12:29:00+00:00By Jack Bacon
MHRA invites Call for Evidence to assess AI regulation
2026-01-27T15:25:00+00:00By Rebecca Harding
FDA and EMA publish guiding principles of good AI practice in drug development
2026-01-27T11:42:00+00:00By Rebecca Harding
2025 UK MDR Regulatory Conference: Meeting report
2026-01-14T09:46:00+00:00By John Wilkinson OBE, Steve Lee and Claire McDermott
The evolving role of the regulatory professional in the age of Artificial Intelligence
2026-01-14T09:45:00+00:00By Peter Lassoff
Empowering digital innovation in CMC: A framework for regulatory readiness and confidence
2026-01-14T09:44:00+00:00By Dr Ian Houson, Professor Walkiria Schlindwein, Dr Chantal Mustoe and Professor Daniel Markl

Overview of the regulatory and development landscape for brain-computer interfaces in neurodegenerative disease treatment
2026-01-14T09:39:00+00:00By Zabin Younes, Maria Beatrice Panico and Tauheed Ibrahim
MD7: Updates on Artificial Intelligence legislation and policy
2025-11-18T10:07:00+00:00By Hasnaa Fatehi
MD6: The importance of digital health – Digital Health Applications (DiGA) and the Digital Mental Health Technology Project
2025-11-18T10:06:00+00:00By Steve Lee
MD5: The evolution of the EU Medical Device Regulation
2025-11-18T10:06:00+00:00By Célia Cruz
HM4: Revision of the EU Variation Regulation – Continuing innovation in lifecycle management
2025-11-18T09:55:00+00:00By Jessica Roe
HM3: Applying Artificial Intelligence in real life
2025-11-18T09:44:00+00:00By Natasha Bankowski

More AI stories